171 related articles for article (PubMed ID: 2446855)
1. Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth.
Dumas MY; Fanidi A; Pageaux JF; Courion C; Nemoz G; Prigent AF; Pacheco H; Laugier C
Endocrinology; 1988 Jan; 122(1):165-72. PubMed ID: 2446855
[TBL] [Abstract][Full Text] [Related]
2. Effect of estrogen on adenosine 3'5',cyclic monophosphate in quail oviduct: possible involvement in estradiol-activated growth.
Laugier C; Courion C; Pageaux JF; Fanidi A; Dumas MY; Sandoz D; Nemoz G; Prigent AF; Pacheco H
Endocrinology; 1988 Jan; 122(1):158-64. PubMed ID: 2826110
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and the regulation of cyclic AMP by the triphenylethylene anti-estrogen tamoxifen in the quail oviduct.
Fanidi A; Pageaux JF; Courion C; Fayard JM; Laugier C
Biol Cell; 1991; 72(1-2):181-6. PubMed ID: 1661631
[TBL] [Abstract][Full Text] [Related]
4. Opposite regulation of cAMP concentration in the quail oviduct and the mouse uterus by tamoxifen. Correlation with estrogen-antagonist and estrogen-agonist activity.
Fanidi A; Ahnadi C; Fayard JM; Pageaux JF; Laugier C
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):571-7. PubMed ID: 1314079
[TBL] [Abstract][Full Text] [Related]
5. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
6. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
7. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities.
Fanidi A; Courion-Guichardaz C; Fayard JM; Pageaux JF; Laugier C
Endocrinology; 1989 Sep; 125(3):1187-93. PubMed ID: 2547579
[TBL] [Abstract][Full Text] [Related]
8. Effect of dexamethasone on adenosine 3',5'-monophosphate content and phosphodiesterase activities in 3T3-L1 adipocytes.
Elks ML; Manganiello VC; Vaughan M
Endocrinology; 1984 Oct; 115(4):1350-6. PubMed ID: 6207010
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase inhibitor 3-isobutyl-methyl-xanthine affects rabbit ovaries and oviduct.
Sirotkin AV; Chrenek P; Chadio S; Xylouri E; Fotopouloy H; Makarevich AV
Eur J Pharmacol; 2010 Sep; 643(1):145-51. PubMed ID: 20599929
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cyclic nucleotide phosphodiesterase activity.
Vaughan M; Danello MA; Manganiello VC; Strewler GJ
Adv Cyclic Nucleotide Res; 1981; 14():263-71. PubMed ID: 6169258
[No Abstract] [Full Text] [Related]
12. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
Miot F; Erneux C
Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
[TBL] [Abstract][Full Text] [Related]
13. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
14. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
Kuo JF; Shoji M; Brackett NL; Helfman DM
J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
[TBL] [Abstract][Full Text] [Related]
15. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
Sobolev AS; Rybalkin SD
Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.
Epstein PM; Hachisu R
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():303-24. PubMed ID: 6202124
[No Abstract] [Full Text] [Related]
17. [Effect of several hormones on cyclic 3',5'-nucleotide phosphodiesterase in rat kidneys].
Iwase K
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1678-91. PubMed ID: 6319206
[TBL] [Abstract][Full Text] [Related]
18. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
Azhaeva EV; Severin ES
Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
[TBL] [Abstract][Full Text] [Related]
19. Hormonal regulation of 3',5'-adenosine monophosphate phosphodiesterases in cultured rat granulosa cells.
Conti M; Kasson BG; Hsueh AJ
Endocrinology; 1984 Jun; 114(6):2361-8. PubMed ID: 6202500
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
